KIF16B Mediates Anterograde Transport and Modulates Lysosomal Degradation of the HIV-1 Envelope Glycoprotein.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
27 07 2023
Historique:
pmc-release: 26 12 2023
medline: 28 7 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) is incorporated into virions at the site of particle assembly on the plasma membrane (PM). The route taken by Env to reach the site of assembly and particle incorporation remains incompletely understood. Following initial delivery to the PM through the secretory pathway, Env is rapidly endocytosed, suggesting that recycling is required for particle incorporation. Endosomes marked by the small GTPase Rab14 have been previously shown to play a role in Env trafficking. Here, we examined the role of KIF16B, the molecular motor protein that directs outward movement of Rab14-dependent cargo, in Env trafficking. Env colocalized extensively with KIF16B

Identifiants

pubmed: 37358446
doi: 10.1128/jvi.00255-23
pmc: PMC10373548
doi:

Substances chimiques

Glycoproteins 0
KIF16B protein, human 0
Kinesins EC 3.6.4.4
Rab14 protein, human EC 3.6.1.-
rab GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0025523

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI150486
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Mol Biol. 2011 Jul 22;410(4):582-608
pubmed: 21762802
J Virol. 2020 Apr 16;94(9):
pubmed: 32075939
Nat Rev Mol Cell Biol. 2009 Nov;10(11):765-77
pubmed: 19851335
J Immunol. 1995 Jul 1;155(1):473-88
pubmed: 7602119
J Immunol Methods. 2018 Sep;460:10-16
pubmed: 29894746
Eur J Biochem. 1999 Mar;260(2):482-9
pubmed: 10095785
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7575-80
pubmed: 26034275
FEBS Lett. 1996 Jul 15;390(1):15-20
pubmed: 8706820
PLoS Pathog. 2013;9(4):e1003278
pubmed: 23592992
J Virol. 2008 Oct;82(20):9937-50
pubmed: 18684836
J Virol. 2019 Dec 12;94(1):
pubmed: 31619553
Viruses. 2022 Aug 05;14(8):
pubmed: 36016351
Mol Neurobiol. 2019 Jun;56(6):3854-3864
pubmed: 30215159
EMBO J. 2013 Jul 31;32(15):2125-39
pubmed: 23749212
Nat Rev Mol Cell Biol. 2009 Dec;10(12):854-65
pubmed: 19935668
Trends Microbiol. 2005 Jul;13(7):320-7
pubmed: 15950476
Cell Rep. 2018 Sep 25;24(13):3568-3581
pubmed: 30257216
PLoS Pathog. 2014 Nov 13;10(10):e1004518
pubmed: 25393110
PLoS Pathog. 2017 Jan 27;13(1):e1006181
pubmed: 28129379
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E182-90
pubmed: 26711999
Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):343-8
pubmed: 10618420
Nat Rev Mol Cell Biol. 2009 Oct;10(10):682-96
pubmed: 19773780
J Virol. 2004 Apr;78(7):3429-35
pubmed: 15016865
Nat Biotechnol. 2008 Feb;26(2):235-40
pubmed: 18157118
J Virol. 2004 Jan;78(2):1026-31
pubmed: 14694135
J Virol. 2022 Jul 27;96(14):e0076722
pubmed: 35770989
J Virol. 1996 Oct;70(10):6547-56
pubmed: 8794289
J Virol. 2007 Sep;81(18):9999-10008
pubmed: 17609279
Cell. 2006 Feb 24;124(4):741-54
pubmed: 16497585
J Virol. 2005 Dec;79(23):14804-14
pubmed: 16282480
J Virol. 2019 Oct 15;93(21):
pubmed: 31375589
Curr Opin Cell Biol. 2009 Feb;21(1):59-67
pubmed: 19179063
Cancer Metastasis Rev. 2009 Jun;28(1-2):197-208
pubmed: 19156502
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
J Virol. 2018 Feb 12;92(5):
pubmed: 29212940
J Virol. 1999 Dec;73(12):10508-13
pubmed: 10559369
Retrovirology. 2020 Nov 19;17(1):35
pubmed: 33213476
Virology. 2011 Mar 15;411(2):244-50
pubmed: 21241997
PLoS Pathog. 2016 Jun 21;12(6):e1005700
pubmed: 27327622
J Virol. 2018 Sep 26;92(20):
pubmed: 30068656
J Vis Exp. 2018 Feb 4;(132):
pubmed: 29443092
J Virol. 1992 Nov;66(11):6616-25
pubmed: 1357190
Genes Dev. 2017 May 15;31(10):1036-1053
pubmed: 28637693
Virology. 1997 Nov 24;238(2):305-15
pubmed: 9400603
Proc Natl Acad Sci U S A. 1988 Dec;85(24):9580-4
pubmed: 2849111
Cell Microbiol. 2006 Mar;8(3):387-400
pubmed: 16469052
Dev Cell. 2011 Jan 18;20(1):60-71
pubmed: 21238925
Nat Rev Microbiol. 2007 Mar;5(3):197-208
pubmed: 17304249
Cancer Sci. 2013 Jun;104(6):651-6
pubmed: 23438337
Cell. 2005 May 6;121(3):437-50
pubmed: 15882625
EMBO J. 1996 Nov 1;15(21):5783-8
pubmed: 8918455
Nat Commun. 2015 Mar 30;6:6660
pubmed: 25818806
J Mol Biol. 2015 Mar 27;427(6 Pt B):1413-1427
pubmed: 25659909
Curr Biol. 2007 Jun 19;17(12):R478-86
pubmed: 17580082
Trends Cell Biol. 2013 Dec;23(12):652-62
pubmed: 24119663
J Virol. 2000 May;74(10):4891-3
pubmed: 10775630

Auteurs

Nicholas Weaver (N)

Immunobiology Division, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.
Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.

Jason Hammonds (J)

Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.

Lingmei Ding (L)

Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.

Grigoriy Lerner (G)

Immunobiology Division, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.
Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.

Krista Dienger-Stambaugh (K)

Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.

Paul Spearman (P)

Infectious Diseases, Cincinnati Children's Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH